D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Apple
AAPL
|
$392M |
| 2 |
Starbucks
SBUX
|
$370M |
| 3 |
Pfizer
PFE
|
$338M |
| 4 |
PayPal
PYPL
|
$320M |
| 5 |
Charles Schwab
SCHW
|
$305M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
$1.02B |
| 2 |
XLNX
Xilinx Inc
XLNX
|
$732M |
| 3 |
Netflix
NFLX
|
$415M |
| 4 |
Citigroup
C
|
$312M |
| 5 |
Booking.com
BKNG
|
$289M |
Sector Composition
| 1 | Technology | 19.01% |
| 2 | Consumer Discretionary | 12.74% |
| 3 | Financials | 11.39% |
| 4 | Healthcare | 11.24% |
| 5 | Energy | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4601
Clean Harbors
CLH
$12.9B
| – | – |
-9,523
| Closed | -$950K |
|
4602
Clearwater Paper
CLW
$347M
| – | – |
-6,057
| Closed | -$222K |
|
4603
Columbus McKinnon
CMCO
$430M
| – | – |
-7,463
| Closed | -$345K |
|
4604
Core & Main
CNM
$12.3B
| – | – |
-119,305
| Closed | -$3.62M |
|
4605
Cohen & Steers
CNS
$3.77B
| – | – |
-2,415
| Closed | -$223K |
|
4606
Cogent Biosciences
COGT
$1.69B
| – | – |
-25,813
| Closed | -$221K |
|